These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 25600257)

  • 21. Association of fractures with the incidence of amyotrophic lateral sclerosis.
    Peters TL; Weibull CE; Fang F; Sandler DP; Lambert PC; Ye W; Kamel F
    Amyotroph Lateral Scler Frontotemporal Degener; 2017 Aug; 18(5-6):419-425. PubMed ID: 28316249
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Severe head injury and amyotrophic lateral sclerosis.
    Peters TL; Fang F; Weibull CE; Sandler DP; Kamel F; Ye W
    Amyotroph Lateral Scler Frontotemporal Degener; 2013 May; 14(4):267-72. PubMed ID: 23286749
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Type II diabetes mellitus and the incidence of amyotrophic lateral sclerosis.
    Tsai CP; Lee JK; Lee CT
    J Neurol; 2019 Sep; 266(9):2233-2243. PubMed ID: 31152300
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Amyotrophic lateral sclerosis in Sweden, 1991-2005.
    Fang F; Valdimarsdóttir U; Bellocco R; Ronnevi LO; Sparén P; Fall K; Ye W
    Arch Neurol; 2009 Apr; 66(4):515-9. PubMed ID: 19364937
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Maternal age, exposure to siblings, and risk of amyotrophic lateral sclerosis.
    Fang F; Kamel F; Sandler DP; Sparén P; Ye W
    Am J Epidemiol; 2008 Jun; 167(11):1281-6. PubMed ID: 18367467
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pre-morbid type 2 diabetes mellitus is not a prognostic factor in amyotrophic lateral sclerosis.
    Paganoni S; Hyman T; Shui A; Allred P; Harms M; Liu J; Maragakis N; Schoenfeld D; Yu H; Atassi N; Cudkowicz M; Miller TM
    Muscle Nerve; 2015 Sep; 52(3):339-43. PubMed ID: 25900666
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association between type 2 diabetes and amyotrophic lateral sclerosis.
    Zhang L; Tang L; Huang T; Fan D
    Sci Rep; 2022 Feb; 12(1):2544. PubMed ID: 35169211
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Angiotensin-converting enzyme inhibitors and amyotrophic lateral sclerosis risk: a total population-based case-control study.
    Lin FC; Tsai CP; Kuang-Wu Lee J; Wu MT; Tzu-Chi Lee C
    JAMA Neurol; 2015 Jan; 72(1):40-8. PubMed ID: 25383557
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Loss of a child and the risk of amyotrophic lateral sclerosis.
    Fang F; Ye W; Fall K; Lekander M; Wigzell H; Sparén P; Adami HO; Valdimarsdóttir U
    Am J Epidemiol; 2008 Jan; 167(2):203-10. PubMed ID: 17947219
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Amyotrophic Lateral Sclerosis and the Military: A Population-based Study in the Danish Registries.
    Seals RM; Kioumourtzoglou MA; Hansen J; Gredal O; Weisskopf MG
    Epidemiology; 2016 Mar; 27(2):188-93. PubMed ID: 26583610
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk of Amyotrophic Lateral Sclerosis in Patients With Diabetes: A Nationwide Population-Based Cohort Study.
    Sun Y; Lu CJ; Chen RC; Hou WH; Li CY
    J Epidemiol; 2015; 25(6):445-51. PubMed ID: 25947580
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Blood biomarkers of carbohydrate, lipid, and apolipoprotein metabolisms and risk of amyotrophic lateral sclerosis: A more than 20-year follow-up of the Swedish AMORIS cohort.
    Mariosa D; Hammar N; Malmström H; Ingre C; Jungner I; Ye W; Fang F; Walldius G
    Ann Neurol; 2017 May; 81(5):718-728. PubMed ID: 28437840
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Smoking, snuff dipping and the risk of amyotrophic lateral sclerosis--a prospective cohort study.
    Fang F; Bellocco R; Hernán MA; Ye W
    Neuroepidemiology; 2006; 27(4):217-21. PubMed ID: 17106211
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aggregation of neurologic and neuropsychiatric disease in amyotrophic lateral sclerosis kindreds: a population-based case-control cohort study of familial and sporadic amyotrophic lateral sclerosis.
    Byrne S; Heverin M; Elamin M; Bede P; Lynch C; Kenna K; MacLaughlin R; Walsh C; Al Chalabi A; Hardiman O
    Ann Neurol; 2013 Nov; 74(5):699-708. PubMed ID: 23836460
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lifestyle and medical conditions in relation to ALS risk and progression-an introduction to the Swedish ALSrisc Study.
    Chourpiliadis C; Seitz C; Lovik A; Joyce EE; Pan L; Hu Y; Kläppe U; Samuelsson K; Press R; Ingre C; Fang F
    J Neurol; 2024 Aug; 271(8):5447-5459. PubMed ID: 38878106
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of Amyotrophic Lateral Sclerosis - United States, 2012-2013.
    Mehta P; Kaye W; Bryan L; Larson T; Copeland T; Wu J; Muravov O; Horton K
    MMWR Surveill Summ; 2016 Aug; 65(8):1-12. PubMed ID: 27490513
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Type 2 diabetes and amyotrophic lateral sclerosis.
    Kawada T
    Eur J Neurol; 2016 Feb; 23(2):e9. PubMed ID: 26806221
    [No Abstract]   [Full Text] [Related]  

  • 38. Occupational Exposure to Electric Shocks and Magnetic Fields and Amyotrophic Lateral Sclerosis in Sweden.
    Fischer H; Kheifets L; Huss A; Peters TL; Vermeulen R; Ye W; Fang F; Wiebert P; Vergara XP; Feychting M
    Epidemiology; 2015 Nov; 26(6):824-30. PubMed ID: 26414853
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mortality statistics for multiple sclerosis and amyotrophic lateral sclerosis in Sweden.
    Boström I; Riise T; Landtblom AM
    Neuroepidemiology; 2012; 38(4):245-9. PubMed ID: 22678224
    [TBL] [Abstract][Full Text] [Related]  

  • 40. No association between proton pump inhibitor use and ALS risk: a nationwide nested case-control study.
    Cetin H; Sun J; Almqvist C; Reichardt B; Tomschik M; Zimprich F; Fang F; Ingre C
    Sci Rep; 2020 Aug; 10(1):13371. PubMed ID: 32770128
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.